FeesSafety
Pluang+

Oracles become crucial for perpetual futures as regulated markets demand robust, transparent price feeds.

Market News
30 May 2026, 16:51 WIB
Crypto Daily
View Source
Bullish
Oracles become crucial for perpetual futures as regulated markets demand robust, transparent price feeds.

Perpetual futures are expanding into regulated and hybrid markets, making the integrity of price oracles a key market structure element. Chainlink is positioning itself by offering decentralized, resilient price feeds and a cross-chain messaging layer (CCIP) that meets regulatory and institutional standards for transparency, uptime, and tamper resistance. Recent regulatory approvals and partnerships, like the CFTC-approved BTCPERP on Kalshi and ICE–OKX oil perps, highlight the growing importance of oracle design in managing risks such as funding rate manipulation and liquidation triggers. Traders and venues must carefully evaluate oracle methodologies, governance, and cross-chain controls to ensure market stability and compliance.

More News

Global Health Congress 2026 unites 625+ leaders, announces startup winners and global expansion plans.

Global Health Congress 2026 unites 625+ leaders, announces startup winners and global expansion plans.

The 2026 Global Health Congress in New York gathered over 625 healthcare leaders from 25 countries to discuss innovation, equity, and investment in healthcare. The event featured 350+ startup applications in its Healthcare Shark Tank competition, cro...

Others
Neutral
2 hours ago
Ambarella schedules Q3 FY2027 earnings call for Nov 24, 2026, with webcast access.

Ambarella schedules Q3 FY2027 earnings call for Nov 24, 2026, with webcast access.

Ambarella, an edge AI semiconductor company, announced its third quarter fiscal year 2027 earnings conference call will be held on November 24, 2026, at 1:30 p.m. Pacific Time. The company will release its earnings report after the market closes that...

Company Fundamentals
Neutral
2 hours ago
INOVIO prices $75M public offering to fund DNA medicine development.

INOVIO prices $75M public offering to fund DNA medicine development.

INOVIO Pharmaceuticals announced a public offering of approximately 58.7 million shares and pre-funded warrants to raise about $75 million before expenses. The offering price is set at $1.05 per share, with an option for underwriters to buy additiona...

Company Fundamentals
Neutral
5 hours ago
US midterm results impact Hyperliquid's regulatory path and crypto policy uncertainty.

US midterm results impact Hyperliquid's regulatory path and crypto policy uncertainty.

The outcome of the US midterm elections will influence Hyperliquid's legislative prospects and the speed of federal compliance efforts, affecting its path toward regulatory approval. Former President Trump has supported Hyperliquid and urged the Comm...

Market News
Neutral
5 hours ago
TRON founder renews legal fight over $107M frozen WLFI tokens amid political shifts in US Congress

TRON founder renews legal fight over $107M frozen WLFI tokens amid political shifts in US Congress

TRON founder Sun Yuchen has intensified his legal battle against World Liberty Financial (WLFI) over about 595 million WLFI tokens frozen since September 2025, worth roughly $107 million at the time. The dispute centers on whether the federal court h...

Market News
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App